Showing results (191-200 of 456) with videos related to

Sort By:
Pageof 46
Small (Weinheim an Der Bergstrasse, Germany)|November 3, 2009
In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cellsV Staedtke, M Brähler, A Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2016
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trialsGiandomenico Roviello, Sandra Sigala, Shahneen Sandhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell CarcinomaCora N Sternberg, Frede Donskov, Naomi B Haas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Recombinant tumor necrosis factor for superficial bladder tumorsC N Sternberg, M G Arena, V Pansadoro, et al.
Oncology|April 30, 2014
Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal diseaseLinda Cerbone, Rita Van Ginderdeuren, Joost Van den Oord, et al.
Cancer|August 15, 2013
Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trialsMichael T Schweizer, Peng Huang, Michael W Kattan, et al.
BJU International|November 17, 2007
Novel agents for muscle-invasive and advanced urothelial cancerGuru Sonpavde, Robert Ross, Thomas Powles, et al.
European Urology|April 3, 2012
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literatureFabio Calabrò, Peter Albers, Carsten Bokemeyer, et al.
Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trialC N Sternberg, J S de Bono, K N Chi, et al.
Pageof 46